Stay updated on Pembrolizumab for Genomic Instability Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial page now displays the study details for the pembrolizumab trial, including its eligibility criteria, study plan, locations, and record dates.
    Difference
    56%
    Check dated 2026-11-09T13:26:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:18:35.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and links to FAQs, including a notice about the agency’s terminology change from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T13:41:54.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:44:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:50.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, replacing the previously loaded study record details. This change blocks viewing core trial information, documents, and contact/location data.
    Difference
    19%
    Check dated 2026-09-21T22:12:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.